Partnership Buy-In Analyzer for Orthopedic Surgeons
Your group just offered you partnership for $350,000. Should you take it? Enter your actual numbers to model the break-even timeline and 10-year income advantage of taking the buy-in versus staying on the associate track.
How to read this
Annual advantage: the extra cash in your pocket each year as a partner, after subtracting the cash buy-in payment (year 1) and loan payments if financed. Red numbers mean you're still recouping up-front costs.
Cumulative advantage: running total from year 1 of partnership. When it turns positive, you've fully recouped the buy-in and are ahead net — that's your break-even.
Orthopedic partnership buy-ins range from $100K to $700K+ depending on group size, geography, and whether ASC equity is included. The income jump from associate to partner (typically $150K–$350K/yr in gross comp, plus potential ASC distributions) usually produces break-even within 1–4 years even for large buy-ins.
- ASC equity value at exit. If your partnership includes ASC ownership, you're buying equity — not just income. A stake producing $300K/yr in distributions may be worth $2–3M when the ASC sells to USPI, SurgCenter, or a hospital system at a 6–10× multiple.
- Tax efficiency of K-1 vs W-2. Partner income on a K-1 gives access to pass-through deductions, Section 199A (if applicable), and business expense treatment. Hospital W-2 income does not.
- Retirement plan stacking. Private practice partners can layer a solo 401(k) + defined benefit plan for $150–400K/yr of tax-advantaged savings — often $100–200K/yr more than a hospital-employed surgeon's 403(b).
- Malpractice tail on transition. If you're leaving a claims-made hospital policy to take this partnership, you may owe $50–150K for tail coverage. That belongs in your break-even math.
- Capital account at exit. Well-structured partnerships return your buy-in capital when you retire. Poorly structured ones don't. This is worth scrutinizing before you sign.
What makes a fair orthopedic buy-in?
There's no universal benchmark, but advisors who work specifically with orthopedic surgeons use these reference points:
- Buy-in relative to annual income lift. A buy-in of 1–1.5× the expected annual comp increase is generally fair (e.g., a $250K buy-in for a $200K comp jump = 1.25×). Buy-ins above 2× the annual lift warrant closer review.
- What you're actually buying. Some buy-ins purchase goodwill only — the right to earn partner-track comp. True equity buy-ins include ownership of accounts receivable, equipment, real estate, or ASC interests. Know which type you're signing before you write the check.
- Capital account vs. non-returnable payment. In a capital-account structure, your buy-in builds a balance returned when you leave. In a flat-payment structure, it's a one-way transfer. The 20-year difference is material.
- ASC buy-in timing and terms. Some groups separate the practice buy-in from the ASC buy-in; others bundle them. Bundled buy-ins can obscure whether the ASC valuation is fair (hint: it often isn't, especially if the group is adding a new surgeon at a favorable-to-themselves price).
Related tools and guides
Have a specific buy-in offer you'd like analyzed?
A specialist advisor will review the actual partnership agreement, model the after-tax economics, evaluate whether ASC equity is fairly priced, and flag terms that could cost you at exit. Free match, no obligation.